Salvia BioElectronics Information

Salvia BioElectronics is pioneering a novel neuromodulation therapy for resistant migraine*. MySalvia Therapy features ultra-thin implants, designed to target key nerves involved in migraine, and is activated by the press of a button on a wearable device. Built for everyday life, it is currently being evaluated in clinical studies. Our commitment is to work toward a future of drug-free relief without compromise, so people with migraine can live life, uninterrupted. Founded in 2017 in Europe’s tech capital Eindhoven, Salvia brings together skilled device makers and MedTech entrepreneurs with extensive experience in medical devices and neuromodulation. Active in the United States and Europe, the company is advancing clinical development with the support of leading investors. Salvia is also exploring the potential of its technology for the treatment of cluster headache. *Resistant migraine is a condition in which significant disability persists despite multiple preventive treatments and is common among people living with chronic migraine.